Apolipoprotein e decreases tau kinases and phospho-tau levels in primary neurons

Molecular Neurodegeneration

Volumn 1, Issue 1, 2006, Pages

  Hoe, Hyang Sook ^a   Freeman, Jacob ^a   Rebeck, G William ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248232920     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-1-18     Document Type: Article

References (47)

1. Gotz J, Chen F, van Dorpe J, Nitsch RM: Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Abeta 42 fibrils. Science 2001, 293(5534):1491-1495.
2. Mandelkow EM, Mandelkow E: Tau protein and Alzheimer's disease. Neurobiol Aging 1994, 15 Suppl 2:S85-6.
3. Mandelkow E: Alzheimer's disease. The tangled tale of tau. Nature 1999, 402(6762):588-589.
4. Genis I, Gordon I, Sehayek E, Michaelson DM: Phosphorylation of tau in apolipoprotein E-deficient mice. Neurosci Lett 1995, 199(1):5-8.
5. Morishima-Kawashima M, Hasegawa M, Takio K, Suzuki M, Yoshida H, Titani K, Ihara Y: Proline-directed and non-proline-directed phosphorylation of PHF-tau. J Biol Chem 1995, 270(2):823-829.
6. Strittmatter WJ, Roses AD: Apolipoprotein E and Alzheimer disease. Proc Natl Acad Sci USA 1995, 92(11):4725-4727.
7. Schmechel DE, Saunders AM, Strittmatter WJ, Grain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD: Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993, 90(20):9649-9653.
8. Rebeck GW, Reiter JS, Strickland DK, Hyman ET: Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993, 11 (4):575-580.
9. Strittmatter WJ, Burke JR, DeSerrano VS, Huang DY, Matthew W, Saunders AM, Scott BL, Vance JM, Weisgraber KH, Roses AD: Protein: protein interactions in Alzheimer's disease and the CAG triplet repeat diseases. Gold Spring Harb Symp Quant Biol 1996, 61:597-605.
10. Nagy Z, Esiri MM, Jobst KA, Johnston C, Litchfield S, Sim E, Smith AD: Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 1995, 69:757-761.
11. Pitas RE, Boyles JK, Lee SH, Hui D, Weisgraber KH: Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins in cerebrospinal fluid and identification of apolipoprotein B,E(LDL) receptors in the brain. J Biol Chem 1987, 262:14352-14360.
12. Poirier J, Hess M, May PC, Finch CE: Cloning of hippocampal poly(A) RNA sequences that increase after entorhinal cortex lesion in adult rat. Brain Res Mol Brain Res 1991, 9(3):191-195.
13. Page KJ, Hollister RD, Hyman BT: Dissociation of apolipoprotein and apolipoprotein receptor response to lesion in the rat brain: an in situ hybridization study. Neuroscience 1998, 85(4):1161-1171.
14. Herz J, Beffert U: Apolipoprotein E receptors: linking brain development and Alzheimer's disease. Nat Rev Neurosci 2000, 1(1):51-58.
15. Fagan AM, Murphy BA, Patel SN, Kilbridge JF, Mobley WC, Bu G, Holtzman DM: Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (-/-) mice but impaired clearance of axonal degeneration products following injury. Exp Neural 1998, 151:314-325.
16. Beffert U, Morfini G, Bock HH, Reyna H, Brady ST, Herz J: Reelin-mediated signaling locally regulates protein kinase B/Akt and glycogen synthase kinase 3 beta. J Biol Chem 2002, 277:49958-49964.
17. Arnaud L, Ballif BA, Forster E, Cooper JA: Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development. Curr Biol 2003, 13(1):9-17.
18. Bock HH, Herz J: Reelin activates SRC family tyrosine kinases in neurons. Curr Biol 2003, 13(1):18-26.
19. Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Murphy MC, Cooper JA, Herz J: Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 1999, 24:481-489.
20. Hoe HS, Harris DC, Rebeck GW: Multiple pathways of apolipoprotein E signaling in primary neurons. J Neurochem 2005, 93:145-155.
21. Strittmatter WJ, Saunders AM, Goedert M, Weisgraber KH, Dong LM, Jakes R, Huang DY, PericakVance M, Schmechel D, Roses AD: Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci USA 1994, 91:11183-11186.
22. Nathan BP, Chang KC, Bellosta S, Brisch E, Ge N, Mahley RW, Pitas RE: The inhibitory effect of apolipoprotein E4 on neurite out-growth is associated with microtubule depolymerization. J Biol Chem 1995, 270:19791-19799.
23. Strittmatter WJ, Bova Hill C: Molecular biology of apolipoprotein E. Curr Opm Lipidol 2002, 13(2):119-123.
24. Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, Mahley RW: Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA 2001, 98(15):8838-8843.
25. Qiu Z, Hyman BT, Rebeck GW: Apolipoprotein E receptors mediate neurite outgrowth through activation of p44/42 mitogen-activated protein kinase in primary neurons. J Biol Chem 2004, 279(33):34948-34956.
26. Han X, Cheng H, Fryer JD, Fagan AM, Holtzman DM: Novel Role for Apolipoprotein E in the Central Nervous system. J Biol Chem 2003, 278:8043-8051.
27. Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, Hammer RE, Richardson JA, Herz J: Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 1999, 97: 689-701.
28. Ohkubo N, Mitsuda N, Tamatani M, Yamaguchi A, Lee YD, Ogihara T, Vitek MP, Tohyama M: Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway. J Biol Chem 2001, 276:3046-3053.
29. Hoe HS, Pocivavsek A, Chakraborty G, Fu Z, Vicini S, Ehlers MD, Rebeck GW: Apolipoprotein E receptor 2 interactions with the N-methyl-D-aspartate receptor. J Biol Chem 2006, 281:3425-3431.
30. Ladu MJ, Shah JA, Reardon CA, Getz GS, Bu G, Hu J, Guo L, Van Eldik LJ: Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses. Neurochem Int 2001, 39:427-434.
31. Hoe HS, Rebeck GW: Regulation of ApoE receptor proteolysis by ligand binding. Mol Brain Res 2005, 137:31-39.
32. Genis L, Chen Y, Shohami E, Michaelson DM: Tau hyperphosphorylation in apolipoprotein E-deficient and control mice after closed head injury. J Neurosci Res 2000, 60(4):559-564.
33. Cedazo-Minguez A, Popescu BO, Blanco-Millan JM, Akterin S, Pei JJ, Winblad B, Cowburn RF: Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta. J Neurochem 2003,87(5):1152- 1164.
34. Brich J, Shie FS, Howell BW, Li R, Tus K, Wakeland EK, Jin LW, Mumby M, Churchill G, Herz J, Cooper JA: Genetic modulation of tau phosphorylation in the mouse. J Neurosci 2003, 23(1):187-192.
35. Fagan AM, Bu G, Sun Y, Daugherty A, Holtzman DM: Apolipoprotein E-containing high density lipoprotein promotes neunte outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J Biol Chem 1996, 271(47):30121-30125.
36. Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE: Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994, 264(5160):850-852.
37. Poirier J: Apolipoprotein E in the brain and its role in Alzheimer's disease. J Psychiatry Neurosci 1996, 21(2):128-134.
38. Teter B, Ashford JW: Neuroplasticity in Alzheimer's disease. J Neurosci Res 2002, 70(3):402-437.
39. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K: Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991, 541(1):163-166.
40. Cho HS, Hyman BT, Greenberg SM, Rebeck GW: Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation. J Neuropathol Exp Neurol 2001, 60(4):342-349.
41. Wisniewski T, Frangione B: Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 1992, 135(2):235-238.
42. Harris FM, Brecht WJ, Xu Q, Mahley RW, Huang Y: Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J Biol Chem 2004, 43:44795-44801.
43. Gibb GM, Pearce J, Betts JC, Lovestone S, Hoffmann MM, Maerz W, Blackstock WP, Anderton BH: Differential effects of apolipoprotein E isoforms on phosphorylation at specific sites on tau by glycogen synthase kinase-3 beta identified by nano-electrospray mass spectrometry. FEBS Letters 2000, 485:99-103.
44. Tesseur I, Dorpe JV, Bruynseels K, Bronfman F, Sciot R, Lommel AV, Leuven FV: Prominent Axonopathy and Disruption of Axonal Transport in Transgenic Mice Expressing Human Apolipoprotein E4 in Neurons of Brain and Spinal Cord. Ameican Journal of Pathology 2000, 157:1495-1510.
45. Brecht WJ, Harris FM, Chang S, Tesseur I, Yu GQ, Xu Q, Fish JD, Wyss-Coray T, Buttini M, Mucke L, Mahley RW, Huang Y: Neuron-specific Apolipoprotein E4 proteolysis is associated with increased Tau phosphorylation in brains of Transgenic mice. J Neurosci 2004, 24:2527-2534.
46. Xu Q, Bernardo A, Walker D, Kanegawa T, Mahley RW, Huang Y: Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J Neurosci 2006, 26:4985-4994.
47. Flaherty D, Lu Q, Soria J, Wood JG: Regulation of Tau Phosphorylation in Microtubule Fractions by Apolipoprotein E. J Neurosci Res 1999, 56:271-274.